Weight-loss drugs reshape clothing purchases for millions in the UK and US

Weight-loss drugs are transforming shopping habits for millions in the UK and US. As users of GLP-1 medications like Wegovy and Mounjaro experience significant weight loss, their clothing choices and spending patterns are changing dramatically. This shift was highlighted by research from PwC, which noted that 5% of UK adults are currently using these drugs, with numbers expected to rise to 13% by the end of next year.

Impact of GLP-1 Drugs on Consumer Behavior

As individuals drop sizes, they are not only changing their wardrobes but also increasing their overall spending on apparel and related products. Hayley Grice, a 50-year-old from Shropshire, who lost seven sizes after starting Mounjaro, expressed her newfound confidence: “I’m very happy with my physique right now.” She now shops in standard stores instead of plus-size retailers, illustrating a broader trend among users of these medications.

In the US, where 21% of adults have tried GLP-1 drugs, spending on clothing, groceries, and alcohol has shifted significantly. This trend is mirrored in the UK, where nearly 3 million people are currently on these drugs. PwC indicates that GLP-1 medications are creating a new consumer demographic, significantly affecting shopping habits.

Demographics of GLP-1 Users

Research shows that approximately 60% of GLP-1 users are women, with a notable portion coming from diverse income backgrounds. About 6% of users are from lower-income households, while 20% belong to the wealthiest demographic. Notably, 83% of potential users indicated they would prefer a pill form of the medication, which is expected to boost uptake further.

Usage statistics reveal that 10% of women aged 35-54 are currently using these drugs, with peak usage occurring among those aged 25-44 at 13%. Such demographics indicate a significant market shift, particularly as more individuals embrace healthier lifestyles.

Market Predictions and Future Trends

The introduction of GLP-1 pills in the UK is anticipated to further increase demand. The Wegovy tablet, available for private prescription, has already shown strong sales potential in the US. Analysts from Berenberg suggest that the overall UK clothing market could see a 1% boost due to the popularity of these medications.

As more consumers adopt these drugs, the potential for increased spending on clothing and accessories becomes apparent. Former M&S director Stephen Fitzgerald notes that predictions suggest 10-15% of the UK population could be on these medications by 2030, which would have significant implications for apparel retailers.

• GLP-1 drugs like Wegovy and Mounjaro are changing shopping habits.
• Current UK users: 5% of adults; projected to rise to 13%.
• 60% of users are women; 83% prefer pill forms.
• Potential 1% boost to the UK clothing market.